3/21/14 Contest update
Biotechs took a tumble on Friday, possibly instigated by some senators who signed a letter kvetching about the price of drugs. Did the senators just return from a trade mission to Colorado? Nonetheless, despite the drubbing of the broader Nasdaq Biotech Index, our marvelous Contest median actually managed a small gain for the week.
At Friday’s close, the Contest median was up 31.63% YTD (vs. up 31.11% YTD a week ago), while the Nasdaq Biotech Index was now up 8.76% YTD (vs. up 11.90% YTD a week ago) and the Nasdaq Composite Index was up 2.40% YTD (vs. up 1.65% YTD a week ago).
Riding an ECYT rocket, GENE’s portfolio, up a sky high 106.11% YTD, shot into first place with a substantial lead. GUERL’s portfolio, up 73.76% YTD, fell to second place and JB118’s portfolio, up 68.99% YTD, held on to third place.
At Friday's close, all 46 Contest portfolios remained in the black and a phenomenal 43 of the 46 are now beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week.
Portfolio adjustments: none
(All corrections, especially adjustments for splits, greatly appreciated.)
Have a terrific first weekend of spring biotechies!
Peace & good health,
Bulba
3/21/14
Rank Name Profit/Loss
1 GENE 106,112
2 GUERL 73,764
3 JB118 68,994
4 ROBERT 60,933
5 NIGEL 57,740
6 BIOMAV 50,904
7 RRGE 50,560
8 DOUGH 50,450
9 MCBIO 49,679
10 CLARK 47,921
Week's Top 5 Gainers
Symbol 3/14 3/21 Wk.%chg.
ECYT 13.65 28.17 106.37%
HZNP 13.15 17.35 31.94%
SKBI 5.71 7.17 25.57%
ECX.DE 6.72 8.20 22.02%
GERN 1.83 2.21 20.77%
Week's Worst 5 Losers
Symbol 3/14 3/21 Wk.%chg.
SSS.V 0.61 0.480 -21.31%
KARO.ST 1.17 0.960 -17.95%
AGEN 4.32 3.640 -15.74%
OHRP 19.65 16.770 -14.66%
XLRN 45.25 39.010 -13.79% |
